Recommendations for patient involvement in health technology assessment in Central and Eastern European countries

Autor: Ivett Jakab, Maria Dimitrova, François Houÿez, Tamás Bereczky, Miroslava Fövényes, Zorana Maravic, Ivica Belina, Christian Andriciuc, Krisztina Tóth, Oresta Piniazhko, Rok Hren, Iñaki Gutierrez-Ibarluzea, Marcin Czech, Tomas Tesar, Maciej Niewada, László Lorenzovici, Maria Kamusheva, Manoela Manova, Alexandra Savova, Zornitsa Mitkova, Konstantin Tachkov, Bertalan Németh, Zsuzsanna Ida Petykó, Dalia Dawoud, Diana Delnoij, Saskia Knies, Wim Goettsch, Zoltán Kaló

Publikováno v: Frontiers in Public Health, Vol 11 (2023)

IntroductionMeaningful patient involvement in health technology assessment (HTA) is essential in ensuring that the interests of the affected patient population, their families, and the general public are accurately reflected in coverage and reimburse

Externí odkaz: https://doaj.org/article/591d4b58b631449dbc84d503029cd297

Building a Healthcare Alliance for Resourceful Medicine Offensive Against Neoplasms in Hematology Added Value Framework for Hematologic Malignancies: A Comparative Analysis of Existing Tools

Autor: Francesco Cerisoli, Farzad Ali, Tamás Bereczky, Natacha Bolaños, Lars Bullinger, Sujith Dhanasiri, James Gallagher, Sonia García Pérez, Jan Geissler, Yann Guillevic, Kathryn Harrison, Anastasia Naoum, Carla Portulano, Ana E. Rodríguez Vicente, Renate Schulze-Rath, Gabriela Yumi Gómez, Guillermo Sanz, Jesús María Hernández Rivas

Publikováno v: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
Value in Health

OBJECTIVES: The Innovative Medicines Initiative-funded, multistakeholders project Healthcare Alliance for Resourceful Medicine Offensive Against Neoplasms in hematologY (HARMONY) created a task force involving patient organizations, medical associati

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e92fe9270fefc7a49f6fbebef635948a
https://doi.org/10.1016/j.jval.2022.04.1729

[Changes resulting from the implementation of the new EU Clinical Trial Regulation 536/2014 from the perspective of patients]

Autor: Ingrid, Klingmann, Margit, Paul, Tamás, Bereczky, Ananda, Plate, Kerstin, Breithaupt-Grögler, Thomas M, Schindler, Jan, Geissler, T M, Schindler

Publikováno v: Bundesgesundheitsblatt, Gesundheitsforschung, GesundheitsschutzLiteratur.

The currently valid Regulation (EU) 536/2014 on clinical trials with medicinal products for human use brings some innovations that are of great importance for patients who participate in clinical trials and patients with a need for innovative therapi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::7fec00aef0b76ba6eac0d008cfe8d11a
https://pubmed.ncbi.nlm.nih.gov/36515718

Methods to Generate Innovative Research Ideas and Improve Patient and Public Involvement in Modern Epidemiological Research: Review, Patient Viewpoint, and Guidelines for Implementation of a Digital Cohort Study

Autor: Gloria A, Aguayo, Catherine, Goetzinger, Renza, Scibilia, Aurélie, Fischer, Till, Seuring, Viet-Thi, Tran, Philippe, Ravaud, Tamás, Bereczky, Laetitia, Huiart, Guy, Fagherazzi

Publikováno v: Journal of Medical Internet Research

Background Patient and public involvement (PPI) in research aims to increase the quality and relevance of research by incorporating the perspective of those ultimately affected by the research. Despite these potential benefits, PPI is rarely included

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::a828c6cae319f93f0f276ce119571659
https://pubmed.ncbi.nlm.nih.gov/34941554

Core outcome set measurement for future clinical trials in acute myeloid leukemia: the HARMONY study protocol using a multi-stakeholder consensus-based Delphi process and a final consensus meeting

Autor: Brian J. P. Huntly, Paula R Williamson, Kathryn L. Harrison, Katharina Lang, Tamás Bereczky, Renate Schulze-Rath, Lars Bullinger, Jan Geissler, Rory Goodbody, Jesús M. Hernández-Rivas, Helene Chevrou-Severac, Gert J. Ossenkoppele

Publikováno v: Lang, K M, Harrison, K L, Williamson, P R, Huntly, B J P, Ossenkoppele, G, Geissler, J, Bereczky, T, Hernández-Rivas, J M, Chevrou-Séverac, H, Goodbody, R, Schulze-Rath, R & Bullinger, L 2020, ' Core outcome set measurement for future clinical trials in acute myeloid leukemia : The HARMONY study protocol using a multi-stakeholder consensus-based Delphi process and a final consensus meeting ', Trials, vol. 21, no. 1, 437 . https://doi.org/10.1186/s13063-020-04384-1
Trials, 21(1):437. BioMed Central
Trials, Vol 21, Iss 1, Pp 1-6 (2020)
Trials
Digital.CSIC. Repositorio Institucional del CSIC
instname

© The Author(s).
[Background]: Acute myeloid leukemia (AML) is the most common acute leukemia in adults and has an unacceptably low cure rate. In recent years, a number of new treatment strategies and compounds were developed for the treatment

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0d44e0855f14315cfe576bc663b2ee91
https://www.repository.cam.ac.uk/handle/1810/307595